OTC Healthcare - Denmark
OTC Healthcare in Denmark : Market Insight
EXECUTIVE SUMMARY
Danes increasingly willing to self-medicate Cosmetic innovations blurring boundaries Weak consumer confidence in cough remedies Sales of vitamins and dietary supplements mature Danes struggle to digest their modern lifestyles KEY TRENDS AND DEVELOPMENTS
Competition from cosmetic products Private label increasingly relevant in OTC sales Product segmentation is a value driver Danish population is growing older Consumers more willing to self-medicate MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Penetration of Private Label by Sector 2002-2006
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification Advertising Packaging and Labelling Distribution De-reimbursement Vitamins and Dietary Supplements Registration and Classification Generics Consumer Expenditure on Health Goods and Medical Services
Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
Local Company Profiles - Denmark
Cederroth A/S - OTC Healthcare - Denmark
STRATEGIC DIRECTION KEY FACTS
Summary 2 Cederroth A/S: Key Facts
Summary 3 Cederroth A/S: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Table 12 Summary3 Cederroth A/S: Competitive Position 2006
Dansk Droge A/S - OTC Healthcare - Denmark
STRATEGIC DIRECTION KEY FACTS
Summary 4 Dansk Droge A/S: Key Facts
Summary 5 Dansk Droge A/S: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 6 Dansk Droge A/S: Competitive Position 2006
Ferrosan A/S - OTC Healthcare - Denmark
STRATEGIC DIRECTION KEY FACTS
Summary 7 Ferrosan A/S: Key Facts
Summary 8 Ferrosan A/S: Operational Indicators
COMPANY BACKGROUND COMPETITIVE POSITIONING
Summary 9 Ferrosan A/S: Competitive Position 2006
Matas A/S - OTC Healthcare - Denmark
STRATEGIC DIRECTION KEY FACTS
Summary 10 Matas A/S: Key Facts
Summary 11 Matas A/S: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 12 Matas A/S: Competitive Position 2006
Nycomed Danmark A/S - OTC Healthcare - Denmark
STRATEGIC DIRECTION KEY FACTS
Summary 13 Nycomed Danmark A/S: Key Facts
Summary 14 Nycomed Danmark A/S: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 15 Nycomed Danmark A/S: Competitive Position 2006
Wound treatments in Denmark
HEADLINES
SECTOR DATA
Table 13 Sales of Wound Treatments by Subsector: Value 2001-2006
Table 14 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
Table 15 Wound Treatments Company Shares by Retail Value 2002-2006
Table 16 Wound Treatments Brand Shares by Retail Value 2003-2006
Table 17 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
Table 18 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011
